Nicole Murphy - Feb 10, 2025 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Pharm Ops and Tech
Signature
/s/ Samuel Ntonme, attorney-in-fact for Nicole Murphy
Stock symbol
BIIB
Transactions as of
Feb 10, 2025
Transactions value $
-$95,502
Form type
4
Date filed
2/12/2025, 05:47 PM
Previous filing
Feb 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +2.27K +18.24% $0.00 14.7K Feb 10, 2025 Direct
transaction BIIB Common Stock Tax liability -$95.5K -670 -4.55% $142.54 14.1K Feb 10, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -2.27K -100% $0.00 0 Feb 10, 2025 Common Stock 2.27K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.